| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.04. | XMReality AB: XMReality Interim report Group overview, January - March 2024 | 86 | GlobeNewswire (Europe) | Total order intake for Q1 2024 has increased by 54 percent compared to Q1 2023. However, net sales was down year-over-year, and the company's ARR was also down somewhat, both as a result of continued... ► Artikel lesen | |
| 22.04. | CIECH Group will change its name to Qemetica in June | 247 | GlobeNewswire (Europe) | In June, the name of the CIECH Group companies will change. The abbreviation CIECH will be replaced by the new name: Qemetica. The planned change is a further consistent step in the Group's chemical... ► Artikel lesen | |
| 22.04. | Generation Bio Co.: Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting | 128 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today... ► Artikel lesen | |
| 22.04. | Cidara Therapeutics, Inc.: Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results | 223 | GlobeNewswire (Europe) | SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate... ► Artikel lesen | |
| 22.04. | Cidara Therapeutics, Inc.: Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice | 351 | GlobeNewswire (Europe) | SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate... ► Artikel lesen | |
| 22.04. | Brown & Brown, Inc. announces first quarter 2024 results, including total revenues of $1,258 million, an increase of 12.7%; Organic Revenue growth of 8.6%; diluted net income per share of $1.02; Diluted Net Income Per Share - Adjusted of $1.14; and a quar | 91 | GlobeNewswire (Europe) | DAYTONA BEACH, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- Brown & Brown, Inc. (NYSE:BRO) (the "Company") announced its unaudited financial results for the first quarter of 2024. Revenues for the first... ► Artikel lesen | |
| 22.04. | SmartFinancial, Inc.: SmartFinancial Announces Results for the First Quarter 2024 | 147 | GlobeNewswire (Europe) | KNOXVILLE, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- SmartFinancial, Inc. ("SmartFinancial" or the "Company"; NYSE: SMBK), today announced net income of $9.4 million, or $0.55 per diluted common share... ► Artikel lesen | |
| 22.04. | Scorpius Holdings, Inc.: Scorpius Holdings Announces Receipt of Filing Delinquency Notification | 455 | GlobeNewswire (Europe) | DURHAM, N.C., April 22, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing organization (CDMO), received an official notice... ► Artikel lesen | |
| 22.04. | First Bank Announces First Quarter 2024 Net Income of $12.5 Million | 458 | GlobeNewswire (Europe) | HAMILTON, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- First Bank (Nasdaq Global Market: FRBA) (the Bank) today announced results for the first quarter of 2024. Net income for the first quarter of 2024... ► Artikel lesen | |
| 22.04. | iLearningEngines Holdings, Inc.: iLearningEngines Reports Fourth Quarter and Full Year 2023 Results | 163 | GlobeNewswire (Europe) | Fourth quarter revenue grew 39% year-over-year to $116 million Posts record full year revenue of $421 million, up 36% year-over-year, and ARR growth accelerates to 43% year-over-year BETHESDA, Md.... ► Artikel lesen | |
| 22.04. | Fate Therapeutics, Inc.: Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting | 235 | GlobeNewswire (Europe) | Key Therapeutic Mechanisms of Clinical Activity for Autoimmune Diseases, including B cell Depletion, Tissue Infiltration and Immune Reconstitution Data, from Phase 1 Study of FT819 in Relapsed / Refractory... ► Artikel lesen | |
| 22.04. | BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq | 191 | GlobeNewswire (Europe) | HOLMDEL, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring... ► Artikel lesen | |
| 22.04. | Vertex Inc.: Vertex Provides Preliminary Financial Results for First Quarter 2024 and Announces First Quarter Earnings Call Date | 267 | GlobeNewswire (Europe) | KING OF PRUSSIA, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced preliminary financial results for... ► Artikel lesen | |
| 22.04. | Oportun Financial Corporation: Oportun Announces Preliminary Q1 2024 Financial Information | 380 | GlobeNewswire (Europe) | SAN CARLOS, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Oportun Financial Corporation ("Oportun" or the "Company") (Nasdaq: OPRT), a mission-driven fintech, today announced certain preliminary unaudited... ► Artikel lesen | |
| 22.04. | NBT Bancorp Inc. Announces First Quarter 2024 Results | 247 | GlobeNewswire (Europe) | NORWICH, N.Y., April 22, 2024 (GLOBE NEWSWIRE) -- NBT Bancorp Inc. ("NBT" or the "Company") (NASDAQ: NBTB) reported net income and diluted earnings per share for the three months ended March 31, 2024.... ► Artikel lesen | |
| 22.04. | Critical Metals Corp: Critical Metals Appoints Tony Sage as Chief Executive Officer | 160 | GlobeNewswire (Europe) | Dietrich Wanke named President of European Operations to operationalize the Wolfsberg Lithium Project, a cornerstone asset for Europe's electric vehicle industry Joint Venture with the Obeikan Investment... ► Artikel lesen | |
| 22.04. | Capital Bancorp, Inc. Reports First Quarter 2024 Results | 521 | GlobeNewswire (Europe) | Net Income of $6.6 million, or $0.47 per share. Net Income, as adjusted(1) of $7.1 million, or $0.51 per shareROAA of 1.15% and ROAE of 10.19% for 1Q 2024Adjusted Metrics(1) excluding Merger-Related... ► Artikel lesen | |
| 22.04. | Pyrophyte Acquisition Corp. Receives NYSE Notice Regarding Delayed Form 10-K Filing | 27 | GlobeNewswire (Europe) | HOUSTON, TEXAS, April 22, 2024 (GLOBE NEWSWIRE) -- Pyrophyte Acquisition Corp. (NYSE: PHYT) (the "Company") today announced that it received a notice from the New York Stock Exchange (the "NYSE")... ► Artikel lesen | |
| 22.04. | Abeona Therapeutics Inc.: Abeona Therapeutics Provides Regulatory Update on Pz-cel | 158 | GlobeNewswire (Europe) | Receives FDA Complete Response Letter (CRL) based on need for additional CMC information CRL did not identify deficiencies related to clinical efficacy or clinical safety data in BLA, and no new... ► Artikel lesen | |
| 22.04. | Clover Health Investments, Corp.: Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer | 306 | GlobeNewswire (Europe) | FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement technology company, today announced... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 1.682 |
| NEL | 1.667 |
| SUPER MICRO COMPUTER | 1.656 |
| NVIDIA | 1.649 |
| TUI | 1.484 |
| BAYER | 1.336 |
| RHEINMETALL | 999 |
| RENK GROUP | 930 |
| PROSIEBENSAT.1 | 912 |
| VOLKSWAGEN | 735 |
| AMAZON | 699 |
| PALANTIR TECHNOLOGIES | 698 |
| TESLA | 687 |
| MICROSTRATEGY | 636 |
| DEUTSCHE BANK | 584 |
| PLUG POWER | 571 |
| BASF | 565 |
| BYD | 557 |
| THYSSENKRUPP | 542 |
| COMMERZBANK | 535 |
| AIXTRON SE | 532 |
| SAP | 507 |
| MERCEDES-BENZ | 506 |
| ALLIANZ | 493 |
| DEUTSCHE TELEKOM | 473 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
